Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling

Miani Vial C, Martin A, Exley J, Doble B, Wilson E, Payne R, Avery A, Meads C, Kirtley A, Jones MM, King S (2017)
Health Technology Assessment 21(78): 1-128.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ; ; ; ; ;
Erscheinungsjahr
Zeitschriftentitel
Health Technology Assessment
Band
21
Zeitschriftennummer
78
Seite
1-128
PUB-ID

Zitieren

Miani Vial C, Martin A, Exley J, et al. Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling. Health Technology Assessment. 2017;21(78):1-128.
Miani Vial, C., Martin, A., Exley, J., Doble, B., Wilson, E., Payne, R., Avery, A., et al. (2017). Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling. Health Technology Assessment, 21(78), 1-128. doi:10.3310/hta21780
Miani Vial, C., Martin, A., Exley, J., Doble, B., Wilson, E., Payne, R., Avery, A., Meads, C., Kirtley, A., Jones, M. M., et al. (2017). Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling. Health Technology Assessment 21, 1-128.
Miani Vial, C., et al., 2017. Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling. Health Technology Assessment, 21(78), p 1-128.
C. Miani Vial, et al., “Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling”, Health Technology Assessment, vol. 21, 2017, pp. 1-128.
Miani Vial, C., Martin, A., Exley, J., Doble, B., Wilson, E., Payne, R., Avery, A., Meads, C., Kirtley, A., Jones, M.M., King, S.: Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling. Health Technology Assessment. 21, 1-128 (2017).
Miani Vial, Celine, Martin, Adam, Exley, Josephine, Doble, Brett, Wilson, Ed, Payne, Rupert, Avery, Anthony, Meads, Catherine, Kirtley, Anne, Jones, Molly Morgan, and King, Sarah. “Clinical effectiveness and cost-effectiveness of issuing longer versus shorter duration (3-month vs. 28-day) prescriptions in patients with chronic conditions: systematic review and economic modelling”. Health Technology Assessment 21.78 (2017): 1-128.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 29268843
PubMed | Europe PMC

Suchen in

Google Scholar